100
Participants
Start Date
March 1, 2023
Primary Completion Date
September 22, 2023
Study Completion Date
December 1, 2023
Dexmedetomidine in 0.9 % NaCl 20 Mcg/5 mL (4 Mcg/mL) INTRAVEN SYRINGE (ML)
Group went under multiple sessions of Dexmedetomidine infusion for 10 sessions; The infusion was provided under non-invasive monitoring for heart rate (HR) and mean arterial pressure (MAP). The infusion rate was adjusted to maintain HR in range of 60-80 beats/min and MAP in range of 65-75 mmHg.
normal saline
Group went under multiple sessions of normal saline injection.
Benha university, Banhā
Benha University
OTHER